HomeInsightsMarket Capitalization

Market Capitalization of Morepen Laboratories Ltd

Market Capitalization of Morepen Laboratories Ltd

stocks purchased

₹ 5.0 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

675.4 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Morepen Laboratories Ltd

NSE: MOREPENLAB

Market Cap

₹ 4057.6 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Morepen Laboratories Ltd is ₹ 4057 crore as of 22 Nov 24 .
  • The Market Cap of Morepen Laboratories Ltd changed from ₹ 775.95 crore on March 2019 to ₹ 2149 crore on March 2024 . This represents a CAGR of 18.51% over 6 years.
  • The Latest Trading Price of Morepen Laboratories Ltd is ₹ 74.02 as of 25 Nov 15:30 .

Historical Market Cap of Morepen Laboratories Ltd

No data available

* All values are in crore

Company Fundamentals for Morepen Laboratories Ltd

No data available

Image

Morepen Laboratories Ltd

NSE: MOREPENLAB

Share Price

₹ 74.02

-0.03 (-0.04%)

stock direction

Last updated on: Nov 25, 2024

Market Price of Morepen Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Morepen Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202474.05
21 Nov 202473.21
19 Nov 202475.87
18 Nov 202474.22
14 Nov 202475.62
13 Nov 202475.52
12 Nov 202479.94
11 Nov 202480.26
08 Nov 202483.31
07 Nov 202484.56

SWOT Analysis Of Morepen Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Morepen Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Morepen Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Morepen Laboratories Ltd

No data available

No data available

Historical P/E Ratio of Morepen Laboratories Ltd

No data available

* All values are in %

Historical Revenue of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Morepen Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Morepen Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Morepen Laboratories Ltd

  • Morepen Laboratories Limited is an India-based pharmaceutical company.
  • Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin.
  • The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast.
  • It has new products added to the therapeutic categories, including Kilbac, Ducal D, Aclomore and Montelast-L. The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India.
  • The main plant at Parwanoo is inspected and approved by United States Food and Drug Administration (USFDA) for production of Loratadine, which is the best selling anti-allergy drug globally.

Morepen Laboratories Ltd News Hub

News

Morepen Laboratories to discuss results

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 11 No...

Read more

08 Nov 202410:49

News

Morepen Laboratories schedules AGM

Morepen Laboratories announced that the Annual General Meeting (AGM) of the company will b...

Read more

12 Sep 202416:01

News

Morepen Laboratories appoints director

Morepen Laboratories has appointed Sharad Jain (DIN: 06423452) as an Independent Director,...

Read more

27 Aug 202415:31

News

Morepen Labs soars after stellar Q1 performance

Net revenue increased by 14% year-over-year (YoY) to Rs 458.64 crore during the period und...

Read more

12 Aug 202412:44

News

Morepen Laboratories to announce Quarterly Result

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 12 Au...

Read more

10 Aug 202416:53

News

Morepen Laboratories successfully concludes QIP issue of Rs 200 cr

Morepen Laboratories announced the successful subscription of a Qualified Institutional Pl...

Read more

06 Aug 202409:09

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Morepen Laboratories Ltd Market Cap

What is the market cap of Morepen Laboratories Ltd?

As of November 25, 2024, Morepen Laboratories Ltd has a market capitalization of ₹4057.6, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Morepen Laboratories Ltd's market capitalization?

Morepen Laboratories Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Morepen Laboratories Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Morepen Laboratories Ltd's market capitalization change?

Morepen Laboratories Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*